Lupin secures U.S. FDA approval for interchangeable biosimilar Ranibizumab
Ranluspec is the only interchangeable ranibizumab biosimilar approved in the United States in both vial and pre-filled syringe (PFS) presentations
Ranluspec is the only interchangeable ranibizumab biosimilar approved in the United States in both vial and pre-filled syringe (PFS) presentations
Subscribe To Our Newsletter & Stay Updated